KRN7000 analog 1 exhibits good Th1-biased immune response through induction of interferon-gamma (IFN-gamma) and reduction of interleukin-4 (IL-4). KRN7000 analog 1 is potential as an antitumor agent and vaccine adjuvant[1].
Molecular Weight:
850.17
Formula:
C47H76FNO9S
Target:
IFNAR,Interleukin Related
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
